Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 41. Johnson P N, Mayes R, Moore E, Neely S, Nguyen A, Miller J L. Ketamine infusions as an adjunct for sedation in critically ill children. Journal of opioid management. 2022; 18 : 57-68
42. Schwier N C, Stephens K, Johnson P N. Management of Idiopathic Viral Pericarditis in the Pediatric Population. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2022; 27 : 595-608
43. Harkin M, Miller J L, Lim S Y, Neely S, Walsh C K, Johnson P N. Conversion From Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit. The Annals of pharmacotherapy. 2021; 55 : 1439-1446
44. Bobo K S, Cober M P, Eiland L S, Heigham M, King M, Johnson P N, Miller J L, Sierra C M. Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021
45. Johnson P N. Pediatric critical care. Central South University Pharmacy. 2021 : 560-84
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 16. OU Health Sciences Center Student Government Association. Robert Magarian Faculty Award. Date: 2017.
17. American Association of Colleges of Pharmacy. Walmart Scholar Mentor (for Trisha Lepa). Date: 2016.
18. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.
19. Pediatric Pharmacy Advocacy Group. Fellow (FPPAG). Date: 2016.
20. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2016.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results